- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Gilero, LLC
Total 12020 results
-
Gilead SciencesApproved for marketing
-
Gilead SciencesTerminatedHeart Failure, Congestive
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedHepatitis C, ChronicUnited States, Germany
-
Gilead SciencesCompletedIschemic Heart DiseaseUnited States
-
Gilead SciencesCompletedHCV InfectionUnited Kingdom, Germany, Ireland, United States, Belgium, Puerto Rico, Poland
-
Gilead SciencesCompletedChronic Hepatitis BUnited States
-
Gilead SciencesCompletedChronic Hepatitis CUnited States, Puerto Rico
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedRSV InfectionUnited States
-
Gilead SciencesCompletedHCV InfectionUnited States
-
Gilead SciencesWithdrawn
-
Gilead SciencesCompletedPulmonary Arterial HypertensionUnited States
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States
-
Gilead SciencesCompletedHIV InfectionUnited States, Puerto Rico, Canada
-
Gilead SciencesCompletedPulmonary Hypertension
-
Gilead SciencesCompletedChronic Hepatitis BAustralia
-
Gilead SciencesCompleted
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedCystic FibrosisUnited States, Canada, Australia, New Zealand
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedCystic Fibrosis | Pseudomonas Aeruginosa | Lung InfectionUnited States, Australia, Canada
-
Gilead SciencesCompletedHIV InfectionsUnited Kingdom
-
Gilead SciencesCompletedPulmonary HypertensionUnited States, Australia, Canada
-
Gilead SciencesCompletedHIV InfectionsUnited States
-
Gilead SciencesCompletedPulmonary HypertensionUnited States, Germany, Australia, Belgium, France, Italy
-
Gilead SciencesCompletedStudy to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.Pulmonary Arterial Hypertension
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedChronic Hepatitis BUnited States
-
Gilead SciencesCompletedHIV | Human Immunodeficiency Virus | HIV-1United States, Puerto Rico
-
Gilead SciencesCompleted
-
Gilead SciencesCompleted
-
Gilead SciencesCompleted
-
Kite, A Gilead CompanyRecruitingHigh-risk Large B-cell Lymphoma (LBCL)United States, Austria, Spain, Italy, Australia, Germany, Netherlands, Canada, Portugal, United Kingdom, France
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
Kite, A Gilead CompanyAvailableAcute Lymphoblastic Leukemia | Mantle Cell LymphomaUnited States
-
Kite, A Gilead CompanyAvailableFollicular Lymphoma | Large B-cell LymphomaUnited States, Japan
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory Mantle Cell LymphomaUnited States, Netherlands, Germany, France
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Germany, Netherlands, Canada
-
Kite, A Gilead CompanyCompletedB-cell LymphomaUnited States, Australia, France
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Waldenstrom Macroglobulinemia | Relapsed/Refractory Richter Transformation | Relapsed/Refractory Burkitt Lymphoma | Relapsed/Refractory Hairy Cell LeukemiaUnited States, Spain, Germany, Italy, France, Netherlands, Switzerland, Austria
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Follicular LymphomaUnited States, Spain, United Kingdom, Italy, France, Japan, Germany
-
Kite, A Gilead CompanyActive, not recruitingRelapsed or Refractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyCompletedRelapsed Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL)United States, Netherlands, Canada, France, Germany, Israel
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)United States, Spain, United Kingdom, Canada, Netherlands, Germany, France, Sweden, Israel, Switzerland, Belgium, Australia, Austria, Italy
-
Kite, A Gilead CompanyCompletedRefractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic LymphomaUnited States, Italy
-
Kite, A Gilead CompanyApproved for marketingRelapsed/Refractory Diffuse Large B Cell Lymphoma | Relapsed/Refractory Primary Mediastinal B Cell Lymphoma | Relapsed/Refractory Transformed Follicular Lymphoma | Relapsed/Refractory High-Grade B-Cell LymphomaUnited States